563 related articles for article (PubMed ID: 2529429)
21. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
22. [Chronic myeloproliferative disorders. The new WHO classification].
Thiele J; Kvasnicka HM
Pathologe; 2001 Nov; 22(6):429-43. PubMed ID: 11766643
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of the myeloproliferative disorders: resolving phenotypic mimicry.
Spivak JL
Semin Hematol; 2003 Jan; 40(1 Suppl 1):1-5. PubMed ID: 12682874
[TBL] [Abstract][Full Text] [Related]
24. Chronic myeloproliferative disorders (CMPD).
Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
[TBL] [Abstract][Full Text] [Related]
25. [Chronic myeloproliferative syndromes].
de Ozalla CB; García Suárez J
Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
[No Abstract] [Full Text] [Related]
26. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
Georgii A; Buhr T; Buesche G; Kreft A; Choritz H
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():15-29. PubMed ID: 8951769
[TBL] [Abstract][Full Text] [Related]
27. The histopathology of chronic myeloproliferative diseases.
Georgii A; Buesche G; Kreft A
Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
[TBL] [Abstract][Full Text] [Related]
28. [Histopathology of Ph1-negative chronic myeloproliferative diseases].
Georgii A; Choritz H; Büsche G; Kreft A; Buhr T
Pathologe; 1995 Jan; 16(1):62-9. PubMed ID: 7886016
[TBL] [Abstract][Full Text] [Related]
29. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
30. [Quiz on the topic of infection and surgery. Myeloproliferative syndrome: chronic megakaryocytic granulocytic myelosis with myelofibrosis Philadelphia positive 4/86].
Leutenegger AF; Wüst W
Ther Umsch; 1990 Jul; 47(7):537-8. PubMed ID: 2389239
[No Abstract] [Full Text] [Related]
31. Bone marrow stromal cells in myeloproliferative disorders.
Hirata J; Takahira H; Kaneko S; Nishimura J; Nawata H
Acta Haematol; 1989; 82(1):35-9. PubMed ID: 2505472
[TBL] [Abstract][Full Text] [Related]
32. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
Thiele J; Simon KG; Fischer R; Zankovich R
Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
[TBL] [Abstract][Full Text] [Related]
33. Myelofibrosis in the myeloproliferative disorders.
Ellis JT; Peterson P
Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
[TBL] [Abstract][Full Text] [Related]
34. Quantitative cytomorphology of megakaryocytes in chronic myeloproliferative disorders--analysis of planimetric and numeric characteristics by means of a knowledge based system.
Nafe R; Kaloutsi V; Fritsch RS; Georgii A
Exp Pathol; 1990; 40(4):213-9. PubMed ID: 2098268
[TBL] [Abstract][Full Text] [Related]
35. [Early diagnosis of proliferative bone-marrow diseases with radioactive iron].
Montz R; Schneider C; Treske U
Dtsch Med Wochenschr; 1972 Jun; 97(26):994-1000. PubMed ID: 5038802
[No Abstract] [Full Text] [Related]
36. The value of bone marrow biopsy in chronic myeloid leukaemia.
Seewann HL; Lehnert M; Jüttner F
Haematologia (Budap); 1983; 16(1-4):67-72. PubMed ID: 6592124
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
Zankovich R; Thiele J; Fischer R; Diehl V
Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
[No Abstract] [Full Text] [Related]
38. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
39. The chronic myeloproliferative disorders: an historical perspective.
Steensma DP
Curr Hematol Rep; 2003 May; 2(3):221-30. PubMed ID: 12901343
[TBL] [Abstract][Full Text] [Related]
40. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders.
Nafe R; Georgii A; Kaloutsi V; Fritsch RS; Choritz H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):111-6. PubMed ID: 1683718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]